Ann: NOVACQ(TM) TRIALS DELIVER 37% UPLIFT IN PRAWN SURVIVAL RATES, page-6

Tim Hart might be excited but i feel a little P'd off with RIC management.

They sound like cowboys really - Was it 2015 when they knew from the CSIRO trials that survival rates were significantly increased using Novacq?

Whoever designed and supervised the failed trials need a good shake-up.
The Board need to seriously appraise their own performance and lift their game.

Given that they have actual and planned investments of over $10Mill in the Novacq commercialization strategy to date,
Given that they are over two years into the strategy implementation,
Given that they drip feed snippets to the market, ........(latest video very short on specifics)

I am quite disappointed in their efforts.
I am not surprised that the market appears to be waiting for further confirmation of their ability to harness the huge tailwinds that Novacq provides to RIC.

All the conjecture on land based animals etc should not be needed to ignite buying interest in RIC.
Novacq for prawns alone is enough of a potential gold mine.

Having ventilated my frustration on progress, i am very confident on the medium - long term potential
of Novacq for adding value for RIC SH's.

GLTH